Posted by Michael Wonder on 19 Jul 2019
Was it really a smart move for the FDA to approve a ‘smart pill’ for treating schizophrenia?
18 July 2019 - In late 2017, the FDA approved the first so-called smart pill, ushering in a new era of medical care.
The inaugural effort involved embedding a sensor in Abilify, an old drug for treating schizophrenia and bipolar disorder, which can make it easier to track whether patients take their medicine, an especially thorny issue for people suffering from mental illness.
But in a new study, several researchers claim the regulatory endorsement was misguided.
